Spinocid Suspension
Spinosad topical
0.9% w/w
ACI Limited
| Pack size | 60 ml bot |
|---|---|
| Dispensing mode | |
| Source | |
| Agent | |
| Retail Price | 500.00 AED |
Indications
Spinocid Suspension is used for:
Scabies, head lice infestations
Adult Dose
Topical
Scabies
Indicated for topical treatment of scabies infestations
Apply product to skin by rubbing it in to completely cover the body from neck down to feet
Patients with balding scalp: Apply product to scalp, hairline, temples, and forehead as well
Allow to absorb in the skin and dry for 10 minutes before getting dressed
Leave on the skin for >6 hr before showering or bathing
Head Lice
Indicated for topical treatment of head lice infestations
Apply a sufficient amount of product needed to cover the dry scalp, then apply to dry hair
Rinse off with warm water after 10 minutes
Repeat only if live lice are seen 7 days after first treatment
Child Dose
Topical
Scabies
Indicated for topical treatment of scabies infestations in adults and children aged >4 years
Apply product to skin by rubbing it in to completely cover the body from neck down to feet
Patients with balding scalp: Apply product to scalp, hairline, temples, and forehead as well
Allow to absorb in the skin and dry for 10 minutes before getting dressed
Leave on the skin for >6 hr before showering or bathing
Head Lice
Indicated for topical treatment of head lice infestations in adults and children aged >6 months
<6 months
Do not use
>6 months
Apply a sufficient amount of product needed to cover the dry scalp, then apply to dry hair
Rinse off with warm water after 10 minutes
Repeat only if live lice are seen 7 days after first treatment
Renal Dose
Administration
Topical Administration
Topical use only; not for oral, ophthalmic, or intravaginal use
Avoid contact with eyes; if it gets in or near eyes, rinse thoroughly with water
Pediatric patients: Apply only under direct supervision of an adult
Contra Indications
Hypersensitivity
Precautions
Contains benzyl alcohol; toxicity and deaths reported in neonates and infants below the age of 6 months with systemic exposure to benzyl alcohol (ie, neonatal gasping syndrome)
Pregnancy-Lactation
Pregnancy
Active ingredient (spinosad) is not absorbed systemically following topical application, and maternal use is not expected to result in fetal drug exposure
Contains benzyl alcohol; topical benzyl alcohol is unlikely to be absorbed through the skin in clinically relevant amounts; therefore, maternal use is not expected to result in fetal drug exposure
Animal data
No adverse embryofetal effects were seen at oral doses of spinosad up to 200 mg/kg/day in pregnant rats or 50 mg/kg/day in pregnant rabbits administered during organogenesis
Lactation
Active ingredient (spinosad) is not distributed in breast milk; however, caution advised because the benzyl alcohol component may be systemically absorbed; lactating women may choose to pump and discard breast milk for 8 hr (5 half-lives of benzyl alcohol) following application
Interactions
Adverse Effects
Side effects of Spinosad topical :
1-10%
Application site erythema (3%)
Ocular erythema (2%)
Ocular hyperemia (2%)
Application site irritation (1%)
<1%
Application site dryness
Application site exfoliation
Alopecia
Dry skin
Mechanism of Action
Causes neuronal excitation in insects, followed by hyperexcitation, paralysis, and death
Note
Spinocid 0.9% w/w Suspension manufactured by ACI Limited. Its generic name is Spinosad topical. Spinocid is availble in Bangladesh.
Farmaco BD drug index information on Spinocid Suspension is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.